SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
安详世平
Lv4
468 积分
2024-11-03 加入
最近求助
最近应助
互助留言
Complete remissions of HER2-positive trastuzumab-resistant xenografts using a potent [225Ac]Ac-labeled anti-HER2 antibody-drug radioconjugate
3天前
已完结
Abstract 1585: KH815, a novel dual-payload TROP2-directed antibody-drug conjugate, shows potent antitumor efficacy in pre-clinical tumor model
3天前
求助中
In Situ Formation of Nanofibers from Purpurin18‐Peptide Conjugates and the Assembly Induced Retention Effect in Tumor Sites
8天前
已完结
A designed cyclic peptide based on Trastuzumab used to construct peptide-drug conjugates for its HER2-targeting ability
8天前
已完结
In Situ Formation of Nanofibers from Purpurin18‐Peptide Conjugates and the Assembly Induced Retention Effect in Tumor Sites
8天前
已完结
PAK5 promotes the trastuzumab resistance by increasing HER2 nuclear accumulation in HER2-positive breast cancer
9天前
已完结
PAK5 promotes the trastuzumab resistance by increasing HER2 nuclear accumulation in HER2-positive breast cancer
9天前
已完结
HER2-targeted, enzyme-activated liposomes show superior in vivo efficacy in an ovarian cancer model
9天前
已完结
HER2-targeted, enzyme-activated liposomes show superior in vivo efficacy in an ovarian cancer model
9天前
已完结
Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy
10天前
已完结
没有进行任何应助
感谢
5个月前
感谢
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论